Shanghai Stock Exchange reports 184 percent rise in mid-year dividend payouts by listed companies so far in 2024 - Global Times
688399 Stock | 63.00 2.72 4.14% |
About 62% of Jiangsu Bioperfectus' investor base is looking to short. The analysis of current outlook of investing in Jiangsu Bioperfectus Technologies suggests that many traders are alarmed regarding Jiangsu Bioperfectus' prospects. The current market sentiment, together with Jiangsu Bioperfectus' historical and current headlines, can help investors time the market. In addition, many technical investors use Jiangsu Bioperfectus stock news signals to limit their universe of possible portfolio assets.
Jiangsu |
Shanghai Stock Exchange reports 184 percent rise in mid-year dividend payouts by listed companies so far in 2024 Global Times
Read at news.google.com
Jiangsu Bioperfectus Fundamental Analysis
We analyze Jiangsu Bioperfectus' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jiangsu Bioperfectus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jiangsu Bioperfectus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Jiangsu Bioperfectus is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Jiangsu Bioperfectus Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jiangsu Bioperfectus stock to make a market-neutral strategy. Peer analysis of Jiangsu Bioperfectus could also be used in its relative valuation, which is a method of valuing Jiangsu Bioperfectus by comparing valuation metrics with similar companies.
Peers
Jiangsu Bioperfectus Related Equities
002998 | Elite Color | 0.95 |
| ||
002303 | Shenzhen MYS | 1.12 |
| ||
002973 | Qiaoyin Environmental | 1.61 |
| ||
688739 | Liaoning Chengda | 2.56 |
| ||
603077 | Sichuan Hebang | 2.94 |
| ||
300463 | Maccura Biotechnology | 3.18 |
| ||
688639 | Anhui Huaheng | 3.97 |
|
Complementary Tools for Jiangsu Stock analysis
When running Jiangsu Bioperfectus' price analysis, check to measure Jiangsu Bioperfectus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jiangsu Bioperfectus is operating at the current time. Most of Jiangsu Bioperfectus' value examination focuses on studying past and present price action to predict the probability of Jiangsu Bioperfectus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jiangsu Bioperfectus' price. Additionally, you may evaluate how the addition of Jiangsu Bioperfectus to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stocks Directory Find actively traded stocks across global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |